For research use only. Not for therapeutic Use.
PRDX1-IN-1(CAT: I041005) is a potent and selective Peroxiredoxin 1 (PRDX1) inhibitor, designed for research in oxidative stress-related diseases. PRDX1 plays a key role in cellular redox balance, and its inhibition has potential therapeutic implications in cancer, inflammation, and neurodegenerative diseases. PRDX1-IN-1 effectively modulates PRDX1 activity, offering a valuable tool for investigating redox signaling pathways. This compound is suitable for biochemical, cellular, and preclinical studies exploring oxidative stress mechanisms and therapeutic targeting. Its high specificity and efficacy make it an essential resource for cancer research, immunology, and neurobiology. For research use only; not for human or clinical applications.
| Catalog Number | I041005 |
| Synonyms | [(6aS,6bS,8aS,11R,12aR,14aR)-4,6a,6b,8a,11,14a-hexamethyl-2-oxo-11-[(3,5,6-trimethylpyrazin-2-yl)methylcarbamoyl]-7,8,9,10,12,12a,13,14-octahydropicen-3-yl] (E)-3-phenylprop-2-enoate |
| Molecular Formula | C46H55N3O4 |
| Purity | ≥95% |
| IUPAC Name | [(6aS,6bS,8aS,11R,12aR,14aR)-4,6a,6b,8a,11,14a-hexamethyl-2-oxo-11-[(3,5,6-trimethylpyrazin-2-yl)methylcarbamoyl]-7,8,9,10,12,12a,13,14-octahydropicen-3-yl] (E)-3-phenylprop-2-enoate |
| InChI | InChI=1S/C46H55N3O4/c1-28-33-16-17-37-44(7,34(33)25-36(50)40(28)53-39(51)18-15-32-13-11-10-12-14-32)22-24-46(9)38-26-43(6,20-19-42(38,5)21-23-45(37,46)8)41(52)47-27-35-31(4)48-29(2)30(3)49-35/h10-18,25,38H,19-24,26-27H2,1-9H3,(H,47,52)/b18-15+/t38-,42-,43-,44+,45-,46+/m1/s1 |
| InChIKey | FRYSNRRDKCJCDD-MAYJLFPOSA-N |
| SMILES | CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)NCC6=NC(=C(N=C6C)C)C)C)C)C)C)OC(=O)C=CC7=CC=CC=C7 |
